✦ LIBER ✦

Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group

✍ Scribed by J. Sjöström; C. Blomqvist; H. Mouridsen; A. Pluzanska; S. Ottosson-Lönn; N.-O. Bengtsson; B. Østenstad; I. Mjaaland; M. Palm-Sjövall; E. Wist; V. Valvere; H. Anderson; J. Bergh

Book ID: 117666781
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 110 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(99)00122-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quality of life in patients with metasta

Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian Breast Group

✍ L Hakamies-Blomqvist; M.-L Luoma; J Sjöström; A Pluzanska; M Sjödin; H Mouridsen 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Doxorubicin versus methotrexate both com

Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer—a randomised study with more than 10 years follow-up from the danish breast cancer cooperative group

✍ M Andersson; E Lindegaard Madsen; M Overgaard; C Rose; P Dombernowsky; H.T Mouri 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Doxorubicin versus methotrexate both com

✍ M Andersson; E Lindegaard Madsen; M Overgaard; C Rose; P Dombernowsky; H.T Mouri 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 117 KB

To evaluate the substitution of methotrexate with doxorubicin (Dox) in CMF-(cyclophosphamide, methotrexate, 5-fluorouracil) containing regimen for advanced breast cancer, 415 postmenopausal patients below the age of 66 years, naïve to chemotherapy, were accrued from 1980 to 1984 and followed-up unti

Randomized phase II study of sequential

Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial

✍ Michael Gubanski; Anders Johnsson; Eva Fernebro; Lianna Kadar; Ingegerd Karlberg 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 278 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views